Quick Take on Biosimilars
RazorMetrics
RazorMetrics creates cutting-edge pharmacy cost containment solutions to quickly and easily reduce drug spend.
Pharmacist Josh Canavan talks to AJMC about the safety of biosimilars.
Like generics 20 years ago, biosimilars are hitting a reluctant market. But physicians and patients ?are slowly starting to accept the less expensive alternative to brand biologics. Check it out here:
2025’S Fiduciary Pressures:?How Employers Can Stay Ahead Of Legal Risks
?
Self-funded employers are experiencing unparalleled regulatory and legal scrutiny, with mounting pressure to show they are fiduciary responsible. From ERISA lawsuits to prescription drug cost management, businesses must now navigate risk-laden waters to avoid running aground with significant financial and legal consequences.? Read more here.
?